WOCKPHARMA₹2,219.90

Wockhardt Ltd.

· Pharma & Health
₹ CrorePeersBIOCONSYNGENEASTERDMGLANDPPLPHARMACOHANCELALPATHLABNATCOPHARMMcap ₹35,962 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment1,875.01,718.01,618.01,618.0
+ Capital Work-in-Progress434.0513.0671.0671.0
+ Goodwill953.0977.01,028.01,028.0
+ Other Intangibles53.041.0145.0145.0
+ Intangibles under Development1,288.01,520.01,708.01,708.0
+ Other Non-current Financial Assets65.053.072.072.0
Non-current Financial Assets65.053.072.072.0
+ Deferred Tax Assets579.0549.0477.0477.0
+ Other Non-current Assets218.0195.0199.0199.0
Total Non-current Assets5,465.05,566.05,918.05,918.0
Current Assets
+ Inventories640.0725.0887.0887.0
+ Current Investments0.0422.0412.0412.0
+ Trade Receivables618.0661.0588.0588.0
+ Cash & Cash Equivalents505.0112.0217.0217.0
+ Other Bank Balances24.079.033.033.0
+ Other Current Financial Assets18.054.051.051.0
Current Financial Assets1,165.01,328.01,301.01,301.0
+ Other Current Assets268.0412.0418.0418.0
Total Current Assets2,073.02,465.02,606.02,606.0
Total Assets7,649.08,135.08,615.08,615.0
Equity
+ Equity Share Capital77.081.081.081.0
+ Other Equity / Reserves3,282.04,272.04,859.04,859.0
Equity — Owners of Parent3,359.04,353.04,940.04,940.0
+ Minority Interest303.0304.0341.0341.0
Total Equity3,662.04,657.05,281.05,281.0
Liabilities
+ Borrowings — Non-current891.01,211.01,518.01,518.0
+ Other Non-current Financial Liab170.095.053.053.0
Non-current Financial Liabilities1,061.01,306.01,571.01,571.0
+ Provisions — Non-current28.029.040.040.0
+ Deferred Tax Liabilities35.035.037.037.0
+ Other Non-current Liabilities72.066.064.064.0
Non-current Liabilities1,196.01,436.01,712.01,712.0
+ Borrowings — Current1,221.0648.0607.0607.0
+ Trade Payables766.0592.0563.0563.0
+ Other Current Financial Liab592.0496.0209.0209.0
Current Financial Liabilities2,579.01,736.01,379.01,379.0
+ Provisions — Current39.053.034.034.0
+ Current Tax Liabilities10.015.06.06.0
+ Other Current Liabilities163.0238.0203.0203.0
Current Liabilities2,791.02,042.01,622.01,622.0
Total Liabilities3,987.03,478.03,334.03,334.0
Total Equity & Liabilities7,649.08,135.08,615.08,615.0
Assets — additional as-filed lines
+ Non-current Assets Held for Sale111.0104.091.091.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current—47.085.085.0
+ Dues to Other Creditors — Current—545.0478.0478.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.